SBIA Presents Congresswoman Stephanie Murphy (D-FL) with Champion of Small Business Investing Award

WASHINGTON, D.C. (October 24, 2018) – Today, the Small Business Investor Alliance (SBIA), the leading association of lower middle market private equity funds and investors, recognized Congresswoman Stephanie Murphy (D-FL) for her support of small business investment and presented her with SBIA’s Champion of Small Business Investing Award. Rep. Murphy is among a group of select Members of Congress whom SBIA is honoring in recognition of their support for small business access to capital.

“Congresswoman Murphy has been an incredible advocate for investment in America’s small businesses through her support of the Small Business Investment Company (SBIC) program and her work on the Small Business Committee,” said SBIA President Brett Palmer. “Small business investors empower growth and job creation across the country, and the legislative work of our Small Business Champions in Congress has been instrumental to facilitating greater capital access for America’s entrepreneurs.”

The award was presented to Rep. Murphy at GENICON–a manufacturer of surgical equipment in Winter Park, Florida–by SBIA members Dan Penberthy of Rand Capital and Chris Harris of Advantage Capital, along with GENICON executives and Board Members.

“The support of Congresswoman Murphy improves not only the access to capital for small businesses in her region, but also helps to promote economic and job growth across the USA,” said Mr. Penberthy.

SBICs provide critical growth capital to American small businesses to help them expand their operations and create jobs; they have invested more than $2.6 billion in Florida businesses over the past 10 years.

###

About Rand Capital

Originally licensed in 2002, Rand Capital SBIC, Inc. has been a long-tenured partner of the Small Business Administration’s SBIC program. Rand Capital SBIC has invested over $65 million across more than 55 portfolio businesses with a focus on investing capital in underserved markets and supporting veteran and women-owned businesses. Rand’s ability to fund portfolio investments of $500,000-$2 million, for which there exists a large funding gap, fills a critical need for small businesses seeking growth capital.

About the Small Business Investor Alliance (SBIA)

The Small Business Investor Alliance (SBIA) is the premier organization of lower middle market private equity funds and investors. SBIA works on behalf of its members as a tireless advocate for policies that promote competitive markets and robust domestic investment for growing small businesses. SBIA has been playing a pivotal role in promoting the growth and vitality of the private equity industry for over 50 years. For more information, visit www.SBIA.org or call 202-628-5055.

GENICON Receives Job Creator Award from Florida Governor

2018 Job Creator AwardGENICON is proud to be one of the five selected recipients of the 2018 Job Creator Award, presented by Florida Governor Rick Scott at Enterprise Florida’s (EFI) Board of Directors Meeting held on June 21st in Tampa. On behalf of GENICON’s staff, and shareholders, we are exceedingly honored to be one of Company’s to receive this award, considering the thousands of companies that operate within the State of Florida. From humble beginnings in 1998 to the firm we are today, we continue to both employee Floridians directly, as well as patron Florida based firms that represent the majority of our supply chain. The force multiplier on the Florida economy from firms such as ours could only be measured in magnitudes.

Within the Company’s Customer base, more than 60% of the Company’s revenues are generated from exports to healthcare systems that span the globe. Our Company’s success within this arena can be traced back to the continuing work and support of Enterprise Florida and their focus on trade.

Genicon’s Presence in China

GENICON is proud to announce it’s licensing arrangement with Greenpine Pharma, based in Tianjin China. Following a decade of successful work together in the development of the Laparoscopic Market within China, both companies worked toward further solidifying the GENICON product range presence within the Chinese Market. CEO Haberland stated “China represents one of the fastest growing markets within the entire global healthcare system, and perhaps the single greatest market potential in the history of mankind. Our mutual trust and commitment toward establishing a long term successful presence within China required this next step in our working relationship together.”